ExosomePlus
PrivateLast Round
Early Funding
Apr 9, 2019
Total Funding Raised
$2.37M
Company Overview
ExosomePlus is a biotechnology company that develops extracellular vesicle isolation and characterization platforms for regenerative therapy and diagnostic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExosomePlus Comparables
Compare ExosomePlus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xenohelix Co., Ltd. | 79% | |
| Cell Guidance Systems | 78% | |
| CellBio Scientific | 77% |
ExosomePlus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 9, 2019 |
ExosomePlus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CKD Venture Capital | Early Funding |
| DAYLI Partners | Early Funding |
| POSCO Technology Investment | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased by 113% MoM.
- Jan 21, 2025
Monthly visitors grew 732% MoM, from 50 to 416.
ExosomePlus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ExosomePlus's valuation, stock price, and market status.
Is ExosomePlus a public or private company?
ExosomePlus is a private company.
What is the current stock price of ExosomePlus?
ExosomePlus is a private company with no public stock price. No recent secondary market data is available.
How much is ExosomePlus worth (valuation)?
Valuation information for ExosomePlus is not publicly available.
Can I buy ExosomePlus stock?
ExosomePlus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ExosomePlus's last funding round?
ExosomePlus's most recent funding round was Early Funding on April 9, 2019.
Who are the main investors in ExosomePlus?
Key investors in ExosomePlus include CKD Venture Capital, DAYLI Partners, POSCO Technology Investment.
Will ExosomePlus IPO soon?
No public IPO plans have been announced for ExosomePlus.
How can I track ExosomePlus secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ExosomePlus's secondary market activity and sign up for updates.